Advocacy

In this piece we outline the main discussions and measures we need to see being systematically adopted to inform decision-making about digital solutions in the health sector, and provide examples of where these were not integrated in decision-making processes and with what consequences.

During the Covid-19 pandemic, telemedicine experienced a global boost. Post-pandemic, the telemedicine industry has been valued at a quarter trillion dollars. However, there are issues, ranging from lack of clear guidelines, lack of training for providers, and issues of connectivity, to costs for patients, the remote care being covered by insurance, that providers must understand prior to deploying telemedicine solutions.

An overview of how the EU works extensively with non-EU countries to introduce biometric ID systems in order to "manage" migration and borders, and recommendations on possible ways to mitigate the risks

If you’re in the UK you may know Bounty as the company that distribute packs of samples to pregnant women at midwife appointments. They’re also the ones that were found to have illegally shared the data of over 14 million mums & babies with 39 companies.

This piece is a part of a collection of research that demonstrates how data-intensive systems that are built to deliver reproductive and maternal healthcare are not adequately prioritising equality and privacy.